GL1X · GenesisL1 explorer

MolNFT v1 · #181158 · protein

SARS-cov-2 3CLPRO in complex with N-[4-[[2-(benzotriazol-1-YL)ACETYL]- (3-THIENYLMETHYL)AMINO]PHENYL]CYCLOPROPANECARBOXAMIDE

7LME · 3C-like proteinase: “SARS-cov-2 3CLPRO in complex with N-[4-[[2-(benzotriazol-1-YL)ACETYL]…”. X-ray diffraction, 1 ligand (Y6J), 5 pockets (best druggability 0.76). MolNFT v1 #181158 on GenesisL1: 3D structure, binding sites and…

PDB
7LME
Type
protein
Length
609 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
Y6J
Pockets
5 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30425% helix, 29% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30527% helix, 29% strandP0DTD1

Ligands and binding sites

  • Y6J · ~{N}-[4-[2-(benzotriazol-1-yl)ethanoyl-(thiophen-3-ylmethyl)amino]phenyl]cyclopropanecarboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19040.760.7974empty
24750.600.7577empty
32110.510.7727Y6J
42130.490.7529empty
52170.490.7529Y6J

Interfaces

1 interface between chains.

  • A–B · 1588 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 7LME · SARS-CoV-2 3CLPro in complex with N-[4-[[2-(benzotriazol-1-yl)acetyl]-(3-thienylmethyl)ami… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.